Public Joint Stock Company Polyus Stock Forecast, Price & News

Public Joint Stock Company Polyus (OTCMKTS:OPYGY) Frequently Asked Questions

Is Public Joint Stock Company Polyus a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Public Joint Stock Company Polyus in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Public Joint Stock Company Polyus stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OPYGY, but not buy additional shares or sell existing shares.
View analyst ratings for Public Joint Stock Company Polyus or view top-rated stocks.

How has Public Joint Stock Company Polyus' stock been impacted by Coronavirus?

Public Joint Stock Company Polyus' stock was trading at $66.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OPYGY shares have increased by 22.0% and is now trading at $81.15.
View which stocks have been most impacted by COVID-19.

Are investors shorting Public Joint Stock Company Polyus?

Public Joint Stock Company Polyus saw a increase in short interest in December. As of December 31st, there was short interest totaling 600 shares, an increase of 500.0% from the December 15th total of 100 shares. Based on an average daily volume of 1,900 shares, the short-interest ratio is presently 0.3 days.
View Public Joint Stock Company Polyus' Short Interest.

How were Public Joint Stock Company Polyus' earnings last quarter?

Public Joint Stock Company Polyus (OTCMKTS:OPYGY) posted its quarterly earnings data on Tuesday, November, 23rd. The company reported $2.43 earnings per share for the quarter. The business earned $1.40 billion during the quarter.
View Public Joint Stock Company Polyus' earnings history.

Who are Public Joint Stock Company Polyus' key executives?

Public Joint Stock Company Polyus' management team includes the following people:

• Pavel Sergeevich Grachev, Chief Executive Officer & Director
• Vladimir Anatolyevich Polin, Director & Senior Vice President-Operations
• Mikhail Borisovich Stiskin, Director, Deputy CEO-Economics & Finance
• Alexander Shitov, Vice President-Control & Compliance
• Sergey Lobov, Vice President-Mineral Resources

Who are some of Public Joint Stock Company Polyus' key competitors?

Some companies that are related to Public Joint Stock Company Polyus include Aben Resources (ABNAF), African Gold Group (AGGFF), AIC Mines (A1M), Alacer Gold (ALIAF), ALACERGOLD/IDR UNRESTR (AQG), Alchemy Resources (ALY), Alliance Resources (AGS), Amani Gold (ANL), Amex Exploration (AMXEF), Anaconda Mining (ANXGF), Anglo Australian Resources (AAR), AngloGold Ashanti (AGG), Anova Metals (AWV), Apollo Consolidated (AOP) and Argo Gold (ARQ).
View all of OPYGY's competitors.

What is Public Joint Stock Company Polyus' stock symbol?

Public Joint Stock Company Polyus trades on the OTCMKTS under the ticker symbol "OPYGY."

How do I buy shares of Public Joint Stock Company Polyus?

Shares of OPYGY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Public Joint Stock Company Polyus' stock price today?

One share of OPYGY stock can currently be purchased for approximately $81.15.

What is Public Joint Stock Company Polyus' official website?

The official website for Public Joint Stock Company Polyus is polyus.com.

Where are Public Joint Stock Company Polyus' headquarters?

Public Joint Stock Company Polyus is headquartered at Tverskoy Bul'var, Dom 15, Stroyeniye 1, MOSCOW, 123104, Russian Federation.

How can I contact Public Joint Stock Company Polyus?

Public Joint Stock Company Polyus' mailing address is Tverskoy Bul'var, Dom 15, Stroyeniye 1, MOSCOW, 123104, Russian Federation. The company can be reached via phone at (495) 641-3377.